Pharmaceuticals & Medical Devices: Regulatory Reforms & Global Positioning

India’s pharmaceutical strategy is pivoting from "Volume Leadership" (Generics) to "Value Leadership" (Innovation & R&D). Simultaneously, the Medical Devices sector is undergoing a structural shift towards self-reliance to reduce import dependence, supported by a revamped regulatory framework that recognizes MedTech as a distinct industry separate from drugs.

Global & Domestic Beneficiaries

  • Global South: Nations relying on India for affordable vaccines and generic medicines.
  • Domestic Manufacturers: Beneficiaries of the PLI schemes for Bulk Drugs and Medical Devices.
  • Patients: Access to high-quality affordable medicines via Jan Aushadhi Kendras.
  • R&D Ecosystem: Startups and academia utilizing National Institute of Pharmaceutical Education and Research (NIPER) facilities.

Policy ....

Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy February 2026 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content

Indian Economy & Socio-economic Development